Zai Lab Limited ADR [ZLAB] stock is trading at $18.5, down -2.79%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ZLAB shares have gain 4.88% over the last week, with a monthly amount drifted -2.89%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Scotiabank started tracking the stock with Sector Outperform rating on March 07, 2025, and set its price target to $55. On March 03, 2025, downgrade downgraded it’s rating to Neutral and revised its price target to $36.10 on the stock. Morgan Stanley started tracking the stock assigning an Overweight rating and suggested a price target of $47.50 on December 14, 2023. Cantor Fitzgerald initiated its recommendation with an Overweight and recommended $70 as its price target on August 10, 2023. Macquarie started tracking with an Outperform rating for this stock on January 21, 2022, and assigned it a price target of $64. In a note dated October 12, 2021, Bernstein initiated an Mkt Perform rating.
Zai Lab Limited ADR [ZLAB] stock has fluctuated between $16.82 and $44.34 over the past year. Currently, Wall Street analysts expect the stock to reach $35 within the next 12 months. Zai Lab Limited ADR [NASDAQ: ZLAB] shares were valued at $18.5 at the most recent close of the market. An investor can expect a potential return of 89.19% based on the average ZLAB price forecast.
Analyzing the ZLAB fundamentals
Zai Lab Limited ADR [NASDAQ:ZLAB] reported sales of 441.78M for the trailing twelve months, which represents a growth of 12.75%. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at -0.52%, Pretax Profit Margin comes in at -0.47%, and Net Profit Margin reading is -0.47%. To continue investigating profitability, this company’s Return on Assets is posted at -0.18, Equity is -0.26 and Total Capital is -0.29. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.29.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 18.35 points at the first support level, and at 18.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.76, and for the 2nd resistance point, it is at 19.02.
Ratios To Look Out For
For context, Zai Lab Limited ADR’s Current Ratio is 2.87. Further, the Quick Ratio stands at 2.68, while the Cash Ratio is 1.99. Considering the valuation of this stock, the price to sales ratio is 4.66, the price to book ratio is 2.69.
Transactions by insiders
Recent insider trading involved Amado Rafael, that happened on Dec 31 ’25 when 10787.0 shares were sold. Officer, Amado Rafael completed a deal on Dec 31 ’25 to buy 10787.0 shares. Meanwhile, Chief Legal Officer Edmondson Frazor Titus III sold 8651.0 shares on Dec 16 ’25.
